12/13/2001

Business Week reviews promising new drugs for 2002, including Schering Plough's Clarinex, Bristol-Myers Squibb's Vanlev and Merck's Arcoxia. Analysts expect each drug to generate at least $1 billion in sales in the next few years.

Related Summaries